Press Release (ePRNews.com) - LA MIRADA, Calif. - Sep 28, 2018 - Captek Pharma announces its participation as an exhibitor at the 17th Annual Contract Pharma trade show Sept. 27–28, 2018, in New Brunswick, New Jersey. Representatives will be at Booth 151 to discuss their brand-new facility and answer questions about their product and service offerings.
As a leading softgel contract manufacturer (CMO), Captek is meeting consumers’ increasing demands for pharmaceutical-grade softgels by launching Captek Pharma. The 54,000-square-foot US FDA 21 CFR Part 210/211 compliant facility is exceptionally innovative and highly functional. Constructed with a quality-by-design approach, the facility has cleanroom suites that are segregated and isolated for maximum control during the manufacturing process.
Utilizing science-based innovation, Captek Pharma is uniquely designed with laboratories for research and development and quality control, suites for encapsulation, suites for preparation and the ability to produce gelatin-based shell products.
“Captek Pharma has the ability to manufacture pharmaceutical-grade products for allergies, cough and colds, constipation, flatulence and insomnia, 24/7, and ship directly from the plant in La Mirada, California,” said Paul Hwang, V.P. of quality and regulatory. “Utilizing science-based innovation, Captek Pharma is uniquely designed with laboratories for research and development and quality control, suites for encapsulation, suites for preparation and the ability to produce gelatin-based shell products.”
This is Captek Pharma’s first year to attend Contract Pharma, which hosts lectures and encourages dialogue regarding manufacturing, packaging and laboratory services in the pharmaceutical industry. Captek Pharma’s knowledgeable staff, located at Booth 151, is available to share their expertise on various components of product development, production and distribution. Conference attendees have an opportunity to discuss pharmaceutical-grade formulations, research and development, quality control and quality assurance and speed-to-market flexibility and scale. Source :